When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn inks deal to sell PA-14 or PRO 140 for CCR5 for diagnostic use
CytoDyn Inc
CytoDyn (OTCQB:CYDY-11.7%) executes a license agreement with IncellDX providing the latter with exclusive global rights to sell non-commercial grade quantities of PA-14 (the murine version of PRO 140 for diagnostic use) or PRO 140 for use in the development and commercialization of diagnostic tests for the quantitative measurement of CCR5 in human cells.
More news on: CytoDyn Inc., Healthcare stocks news, Stocks on the move,